文献速递肝胆胰外科围术期管理与 ERAS

高龄对肝细胞癌切除术患者生存的影响:日本全国性调查

Impact of Advanced Age on Survival in Patients Undergoing Resection of Hepatocellular Carcinoma: Report of a Japanese Nationwide Survey.
PubMed 文献 · Ann Surg · 2019-01-01

该队列研究纳入12,587例接受治愈性肝切除术的肝细胞癌患者,按年龄分为40-59岁、60-74岁和≥75岁三组。结果显示高龄组总体生存显著低于年轻组,但无复发生存三组几乎一致,肝细胞癌相关或肝脏相关死亡的累积发生率三组几乎一致,而其他原因死亡的累积发生率显著不同,且随年龄增长其他原因死亡的60年亚分布风险比显著增加。

要点

  • 高龄(≥75岁)肝细胞癌患者肝切除术后总体生存显著低于中青年患者。
  • 三组无复发生存及肝细胞癌相关或肝脏相关死亡累积发生率几乎一致。
  • 其他原因死亡的累积发生率三组显著不同,且随年龄增长风险比显著增加。

核心结论

  • 高龄患者肝切除术后总体生存显著差于中年和年轻患者。
  • 高龄患者其他原因死亡的累积发生率与肝细胞癌相关或肝脏相关死亡在三组间显著不同。

研究设计与样本

  • 全国性随访调查的队列研究,纳入12,587例接受治愈性肝切除术的肝细胞癌患者。
  • 按年龄分组:40-59岁(n=2991)、60-74岁(n=7576)、≥75岁(n=2020)。
  • 比较各组临床病理特征、长期生存及术后累积死亡发生率,并估计3类死亡的年龄别病因特异性亚分布风险比。

主要发现

  • 术前肝功能检查显示≥75岁组凝血酶原活性和血小板计数高于其他年龄组。
  • 总体生存高龄组显著低于年轻组,但无复发生存三组几乎一致。
  • 肝细胞癌相关或肝脏相关死亡的累积发生率三组几乎一致,其他原因死亡的累积发生率三组显著不同。
  • 其他原因死亡的60年亚分布风险比随年龄增长显著增加。

临床怎么用

  • 对高龄肝细胞癌患者行肝切除术前应充分评估其他原因死亡风险,而不仅关注肿瘤复发。
  • 高龄患者术后管理需重视非肝脏相关合并症的预防与处理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The impact of age on survival after hepatic resection for hepatocellular carcinoma (HCC) has not been thoroughly examined. We reviewed the data of a nationwide follow-up survey to determine the outcomes of hepatectomy for HCC in elderly patients. BACKGROUND: Management of malignant diseases in elderly patients has become a global clinical issue because of the increased life expectancy worldwide. Advancements in surgical techniques and perioperative management have reduced age-related contraindications for liver surgery. METHODS: In all, 12,587 patients with HCC who underwent curative hepatic resection were included in this cohort study and classified according to age group [40-59 years (n = 2991), 60-74 years (n = 7576,), and ≥75 years (n = 2020)]. Clinicopathological features, long-term survival, and cumulative incidences of death after hepatic resection were compared among the groups. The cause-specific subdistribution hazard ratios for 3 types of death depending on age were also estimated. RESULTS: Preoperative liver function tests showed that the prothrombin activity and platelet count were higher in the ≥75-year age group than in the other age groups. The overall survival was significantly lower in the elderly than younger patients. However, recurrence-free survival was almost identical among the 3 groups. The cumulative incidence of HCC-related or liver-related death was almost identical among the 3 groups; however, the cumulative incidence of other causes of death was significantly different. The 60-year subdistribution hazard ratio for other causes of death increased remarkably with increasing age. CONCLUSIONS: Elderly patients in this nationwide survey had significantly worse overall survival after hepatectomy than middle-aged and young patients. The cumulative incidence of other causes of death in elderly patients was significantly different from that of HCC-related or liver-related death among the 3 groups.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Kaibori M, Yoshii K, Yokota I, et al. Impact of Advanced Age on Survival in Patients Undergoing Resection of Hepatocellular Carcinoma: Report of a Japanese Nationwide Survey. Ann Surg. 2019. PMID: 28922205. doi:10.1097/SLA.0000000000002526

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。